$9.92
-0.01 (-0.10%)
Open$9.49
Previous Close$9.93
Day High$10.74
Day Low$9.49
52W High$14.21
52W Low$2.19
Volume—
Avg Volume113.3K
Market Cap92.71M
P/E Ratio—
EPS$-9.68
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+305.4% upside
Current
$9.92
$9.92
Target
$40.22
$40.22
$30.63
$40.22 avg
$46.08
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 9.05M | 8.81M | 7.55M |
| Net Income | 1.50M | 1.95M | 1.65M |
| Profit Margin | 16.6% | 22.2% | 21.9% |
| EBITDA | 2.36M | 2.47M | 1.95M |
| Free Cash Flow | 1.28M | 1.29M | 705.7K |
| Rev Growth | -8.9% | +8.5% | +16.9% |
| Debt/Equity | 0.33 | 0.32 | 0.30 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |